Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Dec;78(6):1631–1637. doi: 10.1172/JCI112756

Mechanism of activation of coagulation factor XI by factor XIIa studied with monoclonal antibodies.

H Akiyama, D Sinha, F S Seaman, E P Kirby, P N Walsh
PMCID: PMC423936  PMID: 3491093

Abstract

The interaction of Factor XIIa with Factor XI was investigated using two monoclonal antibodies, one (3Cl) directed against the heavy chain of Factor XIa and the other (5F4) against its light chain. 3C1 either as intact IgG or as Fab' fragment, enhanced the rate of Factor XIa generation in the fluid phase but inhibited it in the presence of kaolin and high molecular weight (HMW) kininogen. In contrast, the Fab' fragments of 5F4 inhibited only the fluid phase activation and had no effect on the surface-mediated activation. 3C1 was found to block the binding of Factor XI to HMW kininogen, whereas 5F4 did not. We conclude: a domain on the heavy chain region of Factor XI is essential for binding to HMW kininogen and for optimal surface-mediated activation by Factor XIIa; and binding of 3C1 to Factor XI changes its conformation rendering it a more favorable substrate for Factor XIIa in the fluid phase.

Full text

PDF
1631

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bajaj S. P. Cooperative Ca2+ binding to human factor IX. Effects of Ca2+ on the kinetic parameters of the activation of factor IX by factor XIa. J Biol Chem. 1982 Apr 25;257(8):4127–4132. [PubMed] [Google Scholar]
  2. Bouma B. N., Griffin J. H. Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII. J Biol Chem. 1977 Sep 25;252(18):6432–6437. [PubMed] [Google Scholar]
  3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  4. Davie E. W., Fujikawa K., Kurachi K., Kisiel W. The role of serine proteases in the blood coagulation cascade. Adv Enzymol Relat Areas Mol Biol. 1979;48:277–318. doi: 10.1002/9780470122938.ch6. [DOI] [PubMed] [Google Scholar]
  5. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  6. Griffin J. H., Cochrane C. G. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Proc Natl Acad Sci U S A. 1976 Aug;73(8):2554–2558. doi: 10.1073/pnas.73.8.2554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Griffin J. H., Cochrane C. G. Recent advances in the understanding of contact activation reactions. Semin Thromb Hemost. 1979 Spring;5(4):254–273. doi: 10.1055/s-0028-1087158. [DOI] [PubMed] [Google Scholar]
  8. Hojima Y., Pierce J. V., Pisano J. J. Hageman factor fragment inhibitor in corn seeds: purification and characterization. Thromb Res. 1980 Oct 15;20(2):149–162. doi: 10.1016/0049-3848(80)90381-3. [DOI] [PubMed] [Google Scholar]
  9. IATRIDIS S. G., FERGUSON J. H. Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system. J Clin Invest. 1962 Jun;41:1277–1287. doi: 10.1172/JCI104590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kerbiriou D. M., Griffin J. H. Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma. J Biol Chem. 1979 Dec 10;254(23):12020–12027. [PubMed] [Google Scholar]
  11. Kirby E. P., McDevitt P. J. The binding of bovine factor XII to kaolin. Blood. 1983 Apr;61(4):652–659. [PubMed] [Google Scholar]
  12. Kurachi K., Davie E. W. Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor). Biochemistry. 1977 Dec 27;16(26):5831–5839. doi: 10.1021/bi00645a030. [DOI] [PubMed] [Google Scholar]
  13. Kurachi K., Fujikawa K., Davie E. W. Mechanism of activation of bovine factor XI by factor XII and factor XIIa. Biochemistry. 1980 Apr 1;19(7):1330–1338. doi: 10.1021/bi00548a011. [DOI] [PubMed] [Google Scholar]
  14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  15. MARGOLIS J. Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation. J Physiol. 1958 Nov 10;144(1):1–22. doi: 10.1113/jphysiol.1958.sp006082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mandle R. J., Colman R. W., Kaplan A. P. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci U S A. 1976 Nov;73(11):4179–4183. doi: 10.1073/pnas.73.11.4179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mannhalter C., Schiffman S., Jacobs A. Trypsin activation of human factor XI. J Biol Chem. 1980 Apr 10;255(7):2667–2669. [PubMed] [Google Scholar]
  18. March S. C., Parikh I., Cuatrecasas P. A simplified method for cyanogen bromide activation of agarose for affinity chromatography. Anal Biochem. 1974 Jul;60(1):149–152. doi: 10.1016/0003-2697(74)90139-0. [DOI] [PubMed] [Google Scholar]
  19. PROCTOR R. R., RAPAPORT S. I. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol. 1961 Sep;36:212–219. doi: 10.1093/ajcp/36.3.212. [DOI] [PubMed] [Google Scholar]
  20. RAPAPORT S. I., PROCTOR R. R., PATCH M. J., YETTRA M. The mode of inheritance of PTA deficiency: evidence for the existence of major PTA deficiency and minor PTA deficiency. Blood. 1961 Aug;18:149–165. [PubMed] [Google Scholar]
  21. Ragni M. V., Sinha D., Seaman F., Lewis J. H., Spero J. A., Walsh P. N. Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood. 1985 Mar;65(3):719–724. [PubMed] [Google Scholar]
  22. Ratnoff O. D. The biology and pathology of the initial stages of blood coagulation. Prog Hematol. 1966;5:204–245. [PubMed] [Google Scholar]
  23. Scott C. F., Sinha D., Seaman F. S., Walsh P. N., Colman R. W. Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay. Blood. 1984 Jan;63(1):42–50. [PubMed] [Google Scholar]
  24. Sinha D., Koshy A., Seaman F. S., Walsh P. N. Functional characterization of human blood coagulation factor XIa using hybridoma antibodies. J Biol Chem. 1985 Sep 5;260(19):10714–10719. [PubMed] [Google Scholar]
  25. Sinha D., Seaman F. S., Koshy A., Knight L. C., Walsh P. N. Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI. J Clin Invest. 1984 Jun;73(6):1550–1556. doi: 10.1172/JCI111361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Thompson R. E., Mandle R., Jr, Kaplan A. P. Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest. 1977 Dec;60(6):1376–1380. doi: 10.1172/JCI108898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Walsh P. N., Bradford H., Sinha D., Piperno J. R., Tuszynski G. P. Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX. J Clin Invest. 1984 May;73(5):1392–1399. doi: 10.1172/JCI111343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Warn-Cramer B. J., Bajaj S. P. Stoichiometry of binding of high molecular weight kininogen to factor XI/XIa. Biochem Biophys Res Commun. 1985 Dec 17;133(2):417–422. doi: 10.1016/0006-291x(85)90922-2. [DOI] [PubMed] [Google Scholar]
  29. van der Graaf F., Greengard J. S., Bouma B. N., Kerbiriou D. M., Griffin J. H. Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI. J Biol Chem. 1983 Aug 25;258(16):9669–9675. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES